Morgan Stanley
BHST

Morgan Stanley’s BioHarvest Sciences BHST Stock Holding History

Morgan Stanley’s Portfolio BHST Stock Details BHST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.29K Hold
3,250
– – ﹤0.01% 7063
2026
Q1 		$14.1K Hold
3,250
– – ﹤0.01% 6846
2025
Q4 		$16.9K Buy
3,250
+3,239
+29,445% +$25.9K ﹤0.01% 6747
2025
Q3 		$104 Sell
11
-50
-82% -$411 ﹤0.01% 7678
2025
Q2 		$411 Buy
61
+54
+771% +$347 ﹤0.01% 7476
2025
Q1 		$43 Buy
+7
New +$40 ﹤0.01% 7774

Other funds holding BHST

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $1.05B AUM 22.99% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Morgan Stanley's BHST Position: Q2 2026 in Review

Morgan Stanley held its BioHarvest Sciences (BHST) position steady in Q2 2026 at 3,250 shares worth $9.29K. The position accounts for ﹤0.01% of the portfolio, ranked #7063.

Morgan Stanley first reported a position in BHST in Q1 2025 and has held it in 6 quarters since. The position peaked at $16.9K in Q4 2025. 19 funds tracked by Wall St. Rank hold BHST as of Q2 2026.

  • Morgan Stanley held 3,250 shares of BioHarvest Sciences worth $9.29K as of Q2 2026.
  • Morgan Stanley left its BioHarvest Sciences share count unchanged in Q2 2026.
  • BioHarvest Sciences made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7063 holding.
  • Morgan Stanley first reported a position in BioHarvest Sciences in Q1 2025 and has held it in 6 quarters since.
  • Morgan Stanley's BioHarvest Sciences position peaked at $16.9K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held BioHarvest Sciences as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.